Peptide Therapy Disclaimer
Important information about educational content, FDA approval, investigational therapies, patient consent, and clinical review.
OVERVIEW
Peptide therapy is an area of growing interest in health optimization, longevity, and wellness. This website content is for educational purposes only and is not medical advice, diagnosis, or treatment. Some peptide drugs are FDA-approved for specific indications; many substances discussed in these resources are investigational, unapproved, or supported by limited human evidence. IHNJ states that it prescribes only FDA-approved peptide therapies when clinically appropriate. Any treatment requires an initial examination, individualized planning, and a signed consent-to-treat form. Inclusion in this resource library does not mean that IHNJ offers or prescribes every item listed.
Proposed Mechanisms
Not applicable.
Potential Applications
Use as the introductory disclaimer above the peptide and related-resource listings.
Pharmacokinetics
Not applicable.
Dosing
Not applicable.
Monitoring
Clinical and legal review before publication; periodic regulatory review after publication.
Side Effects
Not applicable.
Contraindications
Not applicable.
FDA/Investigational Status
General policy statement. FDA approval applies to specific drug products and indications. Compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.
Disclaimer/Notes
Place this disclaimer before any investigational-resource content. Keep treatment decisions individualized and provider-led. Do not imply that educational entries are available services.
Clinical Review Status
Clinical + legal review required before publishing